NYSE
$34.80▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.25BShares out 93.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 10.13Pre-market26.10.13 20:548-KKey event#●●●
ALLIANCEBERNSTEIN HOLDING L.P.
AllianceBernstein (AB) announced that its preliminary assets under management (AUM) decreased to $900 billion as of September 30, 2026, down 2% from the previous month. This decline was driven by market depreciation and net outflows in the Retail and Private Wealth channels, which offset net inflows from institutional clients. However, the firm recorded approximately $6.0 billion in total firmwide net inflows for the quarter ended September 30, 2026.…more
$34.80+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9Pre-market26.10.09 21:13DEFA14AOther
ALLIANCEBERNSTEIN HOLDING L.P.
AllianceBernstein Holding L.P. has filed definitive additional materials with the SEC regarding its upcoming shareholder meeting. This filing provides procedural information for proxy voting and does not contain any material changes to the company's financial status or corporate governance.…more
$34.80+0.00%vs prev closeView filingShare - 10.9Pre-market26.10.09 21:10DEF 14AOther
ALLIANCEBERNSTEIN HOLDING L.P.
AllianceBernstein Holding L.P. (AB) will hold a Special Meeting of Unitholders on November 18, 2026, to consider and approve the adoption of the 2026 Long Term Incentive Plan (LTIP). The meeting will be conducted virtually, and unitholders of record as of September 24, 2026, are eligible to vote.…more
$34.80+0.00%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.12Regular26.10.13 01:10#●●●#●●●
AB Science to Host Web Conference on October 14
AB Science will hold a web conference to discuss its new governance structure and future growth ambitions. The event will provide updates on the company's outlook and include a Q&A session for investors.…more
$34.80+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.9Regular26.10.10 01:23
●●●●●●●● ●●●●● ●●●●●●
AB Science reported an operating loss of €10.4 million for the first half of 2026 and announced a leadership change alongside a new strategic roadmap. While the company is focusing on quality assurance and financial restructuring, ongoing losses and reliance on private placements remain key concerns for investors.…more
$34.80+0.00%vs prev close - 9.29Overnight26.09.29 15:07
●●●●●●●● ●●●●● ●●●●●●
AB Science has postponed key clinical trial timelines to 2027 to prioritize a comprehensive overhaul of its quality management system following a regulatory inspection. The resumption of studies remains subject to final inspection reports and health authority assessments.…more
$34.80+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report